Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Breast Cancer Female × Doxorubicin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 165 Lymphoma, Large B-Cell, Diffuse 90 Lymphoma 90 Precursor Cell Lymphoblastic Leukemia-Lymphoma 72 Sarcoma 60 Hodgkin Disease 50 Lymphoma, Non-Hodgkin 35 Triple Negative Breast Neoplasms 33 Burkitt Lymphoma 33 Leukemia 31 Lymphoma, Mantle-Cell 30 Lymphoma, Follicular 28 Carcinoma, Hepatocellular 26 Multiple Myeloma 23 Ovarian Neoplasms 19 Neoplasms 18 Neoplasm Metastasis 18 Prostatic Neoplasms 17 Osteosarcoma 16 Lymphoma, Large-Cell, Anaplastic 16 Lymphoma, B-Cell 14 Neuroblastoma 13 Lymphoma, Large-Cell, Immunoblastic 13 Urinary Bladder Neoplasms 12 Lymphoma, T-Cell, Peripheral 12 Immunoblastic Lymphadenopathy 12 Inflammatory Breast Neoplasms 11 Stomach Neoplasms 10 Recurrence 10 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 9

Interventions

Tamoxifen 3 pyrotinib 2 abemaciclib 2 Metformin 2 Exercise 2 Cyclophosphamide 2 Capecitabine 2 Bupivacaine 2 Aromatase Inhibitors 2 palbociclib 1 exemestane 1 durvalumab 1 darolutamide 1 Yoga 1 Waiting Lists 1 Vitamin D 1 Tumor Burden 1 Tretinoin 1 Trastuzumab 1 Tocopherols 1 Thioctic Acid 1 Surveys and Questionnaires 1 Surgical Procedures, Operative 1 Standard of Care 1 Sodium Chloride 1 Self-Help Groups 1 Saline Solution 1 Ropivacaine 1 Radiotherapy 1 Radiofrequency Ablation 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04170465 2022-09-10

METNEO

Damanhour University

Phase 2 Completed

Breast Cancer Female

Data powered by HemOnc (CC BY 4.0) Colophon ⚡